首页> 外文期刊>Annals of the American Thoracic Society >Claim-based Analyses of Inhaled Corticosteroid Refill Rates for Asthma: Who's Kidding Whom?
【24h】

Claim-based Analyses of Inhaled Corticosteroid Refill Rates for Asthma: Who's Kidding Whom?

机译:哮喘吸入性糖皮质激素补充率的基于声明的分析:谁在骗谁?

获取原文
获取原文并翻译 | 示例
           

摘要

Asthma is one of the most common chronic conditions in pediatrics. The economic impact of asthma care in the healthcare system is widespread, with disparities in outcomes leading to higher burden in socio-economically disadvantaged populations (1). Despite the existence of national asthma care guidelines for over a decade (2), adherence to daily asthma controller medications remains low (3), and variation in provider practice patterns remain prevalent (4), particularly for children with milder disease. For all of those reasons, research using large population-based administrative databases is essential to identifying key areas for improvements in asthma management strategies. In this issue of Annals ATS, Sloan and colleagues (pp. 131-134) employ a health services research approach to evaluate corticosteroid prescription fill rates across a 5-year period among children enrolled in Tennessee Medicaid (5).
机译:哮喘是小儿最常见的慢性疾病之一。哮喘护理在医疗保健系统中的经济影响是广泛的,结果的差异导致社会经济上处于不利地位的人群的负担增加(1)。尽管已有十多年的国家哮喘护理指南(2),但每天使用哮喘控制药物的依从性仍然很低(3),医疗提供者的行为方式仍然很普遍(4),特别是对于轻度疾病的儿童。由于所有这些原因,使用大型的基于人口的管理数据库进行的研究对于确定改善哮喘管理策略的关键领域至关重要。在本期《 Annals ATS》中,Sloan及其同事(第131-134页)采用了一项健康服务研究方法来评估在田纳西州医疗补助计划中注册的儿童在5年期间的皮质类固醇处方填充率(5)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号